Indicators

The risk for mother-to-child transmission can be reduced significantly by the complementary approaches of providing antiretroviral drugs (as treatment or as prophylaxis) to the mother and antiretroviral prophylaxis to the infant and using safe delivery practices and safer infant feeding.The data will be used to track progress toward global and national goals towards elimination of mother-to-child transmission; to inform policy and strategic planning; for advocacy; and leveraging resources for accelerated scale up.

Percentage of HIV-positive pregnant women provided with ART to reduce the risk of mother-to-child transmission during pregnancy. Numerator: Number of HIV-positive pregnant women who received ARV as recommended by WHO. Denominator: Estimated number of HIV-positive pregnant women

Treatment status at time of pregnancy (already receiving or initiated during pregnancy)

The numerator can be calculated from national programme records aggregated from programme monitoring tools, such as patient registers and summary reporting forms. The denominator of the estimated number of HIV-positive pregnant women is typically obtained using Spectrum, a UNAIDS-supported software tool. Countries with routine antenatal clinic surveillance, in combination with appropriate adjustments related to demographic data and coverage of antenatal care, may be able to use these data to estimate the denominator  

Outcome

Modelling, using multiple inputs specific to the HIV epidemic context, is typically used to obtain an estimate of the number of HIV-positive pregnant women and national programme records are used to determine the number receiving ARV. UNAIDS supports most countries to produce estimates of the number of HIV-positive pregnant women annually using Spectrum

Annual (unless survey-based)